UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of cervical stenosis on the size of brain ventricles and the spinal central canal

British journal of neurosurgery, 2007-10, Vol.21 (5), p.459

2007

Volltextzugriff (PDF)

Validation of the Japanese version of the job crafting scale

Journal of Occupational Health, 2016-05, Vol.58 (3), p.231-240

2016

Volltextzugriff (PDF)

3-D Sewing Technology Using Manipulators

Journal of robotics and mechatronics, 1989-08, Vol.1 (2), p.128-135

1989

Volltextzugriff (PDF)

Improvement of mechanical properties of bio-concrete using Enterococcus faecalis and Bacillus cereus

Environmental engineering research, 2019, Vol.24 (4), p.630-637

2019

Volltextzugriff (PDF)

Optimisation of self-healing of bio-foamed concrete bricks pores using Bacillus tequilensis under different temperature and CO2 curing conditions

Scientific reports, 2022-02, Vol.12 (1), p.2682-2682, Article 2682

2022

Volltextzugriff (PDF)

Practicing cognitive behavior group therapy for sexual offenders using a rolling format in the medical institutions of Japan

Journal of behavioral addictions, 2019-03, Vol.8 (S1), p.28

Tanaka, Juki

2019

Volltextzugriff (PDF)

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

Fertility and sterility, 2017-07, Vol.108 (1), p.152-160.e4

2017

Volltextzugriff (PDF)

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

The New England journal of medicine, 2017-07, Vol.377 (1), p.28-40

2017

Volltextzugriff (PDF)

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis

Clinical pharmacokinetics, 2020-03, Vol.59 (3), p.297-309

2020

Volltextzugriff (PDF)

Unique Crosslinking Properties of Psoralen‐Conjugated Oligonucleotides Developed by Novel Psoralen N‐Hydroxysuccinimide Esters

Chembiochem : a European journal of chemical biology, 2023-08, Vol.24 (15), p.e202200789-n/a

2023

Volltextzugriff (PDF)

Universal features in the lifetime distribution of clusters in hydrogen-bonding liquids

Physical chemistry chemical physics : PCCP, 2021-09, Vol.23 (35), p.19537-19546

2021

Volltextzugriff (PDF)

Modular Synthesis of Methyl-Substituted Novel Psoralen N-Hydroxysuccinimide Esters and Evaluation of DNA Photocrosslinking Properties of the Corresponding Triplex-Forming Oligonucleotide Conjugates

Synlett, 2024-07

2024

Volltextzugriff (PDF)

Therapeutic application of sequence-specific binding molecules for novel genome editing tools

Drug metabolism and pharmacokinetics, 2022-02, Vol.42, p.100427-100427, Article 100427

2022

Volltextzugriff (PDF)

Dose-Dependent Suppression of Gonadotropins and Ovarian Hormones by Elagolix in Healthy Premenopausal Women

The journal of clinical endocrinology and metabolism, 2017-05, Vol.102 (5), p.1683-1691

2017

Volltextzugriff (PDF)

Elagolix With Add-Back Rapidly Improves Nonbleeding Symptoms in Individuals With Fibroid-Associated Heavy Menstrual Bleeding [ID: 1368052]

Obstetrics and gynecology (New York. 1953), 2023-05, Vol.141 (5S), p.13-13S

2023

Volltextzugriff (PDF)

Elagolix Plus Add-Back Consistently Improves Uterine Fibroids-Associated Bleeding and Nonbleeding Symptoms Across Subpopulations [ID: 1368059]

Obstetrics and gynecology (New York. 1953), 2023-05, Vol.141 (5S), p.102-102S

2023

Volltextzugriff (PDF)

Efficacy and Safety of Elagolix 150 mg QD in Women With Uterine Fibroids and Heavy Menstrual Bleeding [A87]

Obstetrics and gynecology (New York. 1953), 2022-05, Vol.139 (1), p.26-26S

2022

Volltextzugriff (PDF)

Applying three pillar indicator assessments on alternative floor systems: life cycle study

The international journal of life cycle assessment, 2021-07, Vol.26 (7), p.1439-1455

2021

Volltextzugriff (PDF)

Mechanical properties of sulphate reduction bacteria on the durability of concrete in chloride condition

MATEC Web of Conferences, 2019, Vol.258, p.1024

2019

Volltextzugriff (PDF)

Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

Clinical pharmacokinetics, 2020-05, Vol.59 (5), p.617-627

2020

Volltextzugriff (PDF)

Long-Term Safety of Elagolix With Add-Back in Women With Endometriosis-Associated Pain: 36-Month Results [ID: 1368036]

Obstetrics and gynecology (New York. 1953), 2023-05, Vol.141 (5S), p.13-13S

2023

Volltextzugriff (PDF)

Front Cover: Unique Crosslinking Properties of Psoralen‐Conjugated Oligonucleotides Developed by Novel Psoralen N‐Hydroxysuccinimide Esters (ChemBioChem 15/2023)

Chembiochem : a European journal of chemical biology, 2023-08, Vol.24 (15), p.n/a

2023

Volltextzugriff (PDF)

Preventing cystatin F proteolytic activation by cathepsin V increases cytotoxicity of effector immune cells

European journal of cancer (1990), 2022-10, Vol.174, p.S124-S124

2022

Volltextzugriff (PDF)

Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist

Journal of clinical pharmacology, 2020-12, Vol.60 (12), p.1606-1616

2020

Volltextzugriff (PDF)

Complex temperature dependence of the dielectric response in simple SmC phases

Soft matter, 2023-03, Vol.19 (11), p.242-246

2023

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(74)
Technology
(37)
Female
(28)
Humans
(28)
Animals
(23)
Male
(23)
Biological And Medical Sciences
(22)
Engineering
(22)
Medical Sciences
(20)
Pharmacology & Pharmacy
(20)
Rats
(18)
Physical Sciences
(17)
Telecommunications
(17)
Toxicology
(16)
Engineering, Electrical & Electronic
(14)
Exact Sciences And Technology
(13)
Adult
(12)
Applied Sciences
(12)
Middle Aged
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of cervical stenosis on the size of brain ventricles and the spinal central canal

Validation of the Japanese version of the job crafting scale

3-D Sewing Technology Using Manipulators

Improvement of mechanical properties of bio-concrete using Enterococcus faecalis and Bacillus cereus

Optimisation of self-healing of bio-foamed concrete bricks pores using Bacillus tequilensis under different temperature and CO2 curing conditions

Practicing cognitive behavior group therapy for sexual offenders using a rolling format in the medical institutions of Japan

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis

Unique Crosslinking Properties of Psoralen‐Conjugated Oligonucleotides Developed by Novel Psoralen N‐Hydroxysuccinimide Esters

Universal features in the lifetime distribution of clusters in hydrogen-bonding liquids

Modular Synthesis of Methyl-Substituted Novel Psoralen N-Hydroxysuccinimide Esters and Evaluation of DNA Photocrosslinking Properties of the Corresponding Triplex-Forming Oligonucleotide Conjugates

Therapeutic application of sequence-specific binding molecules for novel genome editing tools

Dose-Dependent Suppression of Gonadotropins and Ovarian Hormones by Elagolix in Healthy Premenopausal Women

Elagolix With Add-Back Rapidly Improves Nonbleeding Symptoms in Individuals With Fibroid-Associated Heavy Menstrual Bleeding [ID: 1368052]

Elagolix Plus Add-Back Consistently Improves Uterine Fibroids-Associated Bleeding and Nonbleeding Symptoms Across Subpopulations [ID: 1368059]

Efficacy and Safety of Elagolix 150 mg QD in Women With Uterine Fibroids and Heavy Menstrual Bleeding [A87]

Applying three pillar indicator assessments on alternative floor systems: life cycle study

Mechanical properties of sulphate reduction bacteria on the durability of concrete in chloride condition

Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling

Long-Term Safety of Elagolix With Add-Back in Women With Endometriosis-Associated Pain: 36-Month Results [ID: 1368036]

Front Cover: Unique Crosslinking Properties of Psoralen‐Conjugated Oligonucleotides Developed by Novel Psoralen N‐Hydroxysuccinimide Esters (ChemBioChem 15/2023)

Preventing cystatin F proteolytic activation by cathepsin V increases cytotoxicity of effector immune cells

Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist

Complex temperature dependence of the dielectric response in simple SmC phases

Suchergebnisse filtern